SLP

Pre-mercato: 13.96

Simulations Plus Inc (SLP)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché SLP Giù? Forum Previsione Frazionamento azionario Storia dei dividendi

Precedente Chiudi:

Volume 24 ore:

Relative Volume:

Capitalizzazione di mercato:

Utile/perdita netta:

Rapporto P/E:

Flusso di cassa netto:

1 W Prestazione:

1M Prestazione:

6M Prestazione:

1 anno Prestazione:

Intervallo 1D:

Intervallo di 1 settimana:

Portata 52W:

Simulations Plus Inc Stock (SLP) Company Profile

Simulations Plus Inc

Healthcare (1106)

661-723-7723

800 PARK OFFICES DRIVE, SUITE 401, RESEARCH TRIANGLE PARK, CA

@SimulationsPlus

Prossima data di guadagno

Ultimi documenti SEC

SLP's Discussions on Twitter

Compare SLP vs VEEV, BTSG, TEM, HQY, DOCS

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
SLP Simulations Plus Inc	13.96	296.82M	80.54M	-62.79M	20.76M	-3.1233
VEEV Veeva Systems Inc	159.42	26.00B	3.20B	908.91M	1.39B	5.4168
BTSG Brightspring Health Services Inc	55.50	10.68B	13.65B	169.86M	412.12M	1.0758
TEM Tempus Ai Inc	46.95	8.70B	1.36B	-302.91M	-219.93M	-1.7182
HQY Healthequity Inc	80.46	6.90B	1.31B	215.20M	408.32M	2.4627
DOCS Doximity Inc	26.45	4.85B	637.78M	239.40M	307.21M	1.1909

Simulations Plus Inc Stock (SLP) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-12-18	Downgrade	BTIG Research	Buy → Neutral
2025-09-30	Iniziato	TD Cowen	Hold
2025-07-15	Downgrade	KeyBanc Capital Markets	Overweight → Sector Weight
2024-11-15	Iniziato	Stephens	Overweight
2024-07-29	Iniziato	KeyBanc Capital Markets	Overweight
2024-07-16	Iniziato	JMP Securities	Mkt Perform
2024-06-28	Iniziato	William Blair	Outperform
2023-05-09	Iniziato	BTIG Research	Buy
2021-10-26	Aggiornamento	Craig Hallum	Hold → Buy
2021-01-12	Downgrade	Craig Hallum	Buy → Hold
2020-10-16	Iniziato	Raymond James	Outperform
2020-09-08	Iniziato	Oppenheimer	Outperform
2020-01-06	Iniziato	Craig Hallum	Buy

Mostra tutto

Simulations Plus Inc Borsa (SLP) Ultime notizie

Simulations Plus Inc Azioni (SLP) Dati Finanziari

Simulations Plus Inc (SLP)

Simulations Plus Inc Stock (SLP) Company Profile

Compare SLP vs VEEV, BTSG, TEM, HQY, DOCS

Simulations Plus Inc Stock (SLP) Upgrades & Downgrades

Simulations Plus Inc Borsa (SLP) Ultime notizie

TradingKey - TradingKey

[144] Simulations Plus, Inc. SEC Filing - Stock Titan

Nicholas Company Inc. Buys 78,854 Shares of Simulations Plus, Inc. $SLP - MarketBeat

NVIDIA Pushes AI Into Drug Development With Simulations Plus Collaboration - Yahoo Finance

Simulations Plus unveils method for QST model integration with microphysiological data in liver risk analysis - Traders Union

Simulations Plus collaborates with NVIDIA during AI drug modeling push - MSN

Simulations Plus, Inc. (SLP): Investor Outlook With A 47% Potential Upside - DirectorsTalk Interviews

SLP Stock Price, Quote & Chart | SIMULATIONS PLUS INC (NASDAQ:SLP) - ChartMill

Simulations Plus (SLP) Partners with NVIDIA for Advanced Drug De - GuruFocus

Simulations Plus teams with NVIDIA on drug modeling - Engineering.com

Simulations Plus (NASDAQ:SLP) Stock Price Crosses Above Two Hundred Day Moving AverageHere's What Happened - MarketBeat

Simulations Plus and NVIDIA Collaborate to Scale GPU-Accelerated, AI-Assisted Modeling Workflows - HPCwire

Simulations Plus Collaborates With Nvidia During AI Drug Modeling Push - Benzinga

Simulations Plus partners with Nvidia on AI drug development By Investing.com - Investing.com India

Simulations Plus partners with Nvidia on AI drug development - Investing.com

Simulations Plus stock surges 28% on NVIDIA collaboration - Investing.com

Simulations Plus And NVIDIA Collaborate To Scale GPU-Accelerated, AI-Assisted Modeling Workflows - marketscreener.com

Insider Sell Alert: DiBella John Anthony II Sells Shares of Simu - GuruFocus

[Form 4] Simulations Plus, Inc. Insider Trading Activity - Stock Titan

Simulations Plus (SLP) insiders sell 15,000 shares in planned trade - Stock Titan

Do options traders know something about Simulations Plus stock we don't? - MSN

(SLP) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily

Do Options Traders Know Something About Simulations Plus Stock We Don't? - Zacks Investment Research

Simulations Plus (SLP) director receives 2,117-share equity grant as compensation - Stock Titan

Director Sharlene Evans receives 2,117 SLP shares in equity grant - Stock Titan

Director at Simulations Plus (SLP) receives 2,117-share stock grant - Stock Titan

Simulations Plus (SLP) director awarded 2,117 shares as equity compensation - Stock Titan

AI in Predictive Toxicology Research Report 2026 Featuring - GlobeNewswire

AI in Predictive Toxicology Research Report 2026 Featuring Certara, Schrodinger, Instem, Simulations Plus, Lhasa, ChemaxonGlobal Forecast to 2030 and 2035 - Yahoo Finance UK

Global Biosimulation Market Poised for Phenomenal Expansion at a CAGR of ~17% by 2034 | DelveInsight - GlobeNewswire Inc.

Simulations Plus, Inc. (NASDAQ:SLP) Receives Consensus Rating of "Hold" from Brokerages - MarketBeat

Latest SLP NewsSimulations Plus Announces Quarterly Cash Di... - Stock Titan

Simulations Plus Q2 2026 earnings preview - MSN

Certara Strategic Business Divestiture Comes At Right Time, Says Analyst - Sahm

(SLP) Risk Channels and Responsive Allocation - Stock Traders Daily

Simulations Plus shares drop over 12% premarket as Q3 revenue forecast misses expectations - MSN

SLP Simulations Plus posts strong Q1 2026 results, shares rise over four percent on double digit EPS and revenue gains.Debt/Equity - Xã Thanh Hà

Simulations Plus partners with Lonza and FDA on drug formulation research - Investing.com Nigeria

Simulations Plus (SLP) Partners with FDA and Lonza for Drug Perf - GuruFocus

Simulations Plus enters funded research collaboration with Lonza, FDA - TipRanks

Simulations Plus partners with Lonza and FDA on drug formulation research By Investing.com - Investing.com South Africa

Simulations Plus Announces Collaboration with Lonza and U.S. FDA to Advance Predictive Frameworks for Complex Oral Drug Products - Business Wire

SLP SEC FilingsSimulations Plus Inc 10-K, 10-Q, 8-K Forms - Stock Titan

Simulations Plus (SLP) Completes Successful Spring School Traini - GuruFocus

What Happened to Simulations Plus (SLP) Stock Today (Wavering) 2026-04-20Continuation Signals - Cổng thông tin điện tử tỉnh Tây Ninh

Simulations Plus Expands Global Access to Model-Informed Drug Development Training Through Its 2026 Spring School - 01net

Simulations Plus Inc Azioni (SLP) Dati Finanziari

Reddito

Reddito netto

Flusso di cassa

EPS

Simile a SLP